BDNF-induced endocannabinoid release modulates neocortical glutamatergic neurotransmission

Synapse

Volumn 71, Issue 5, 2017, Pages

  Yeh, Mason L ^a   Selvam, Rajamani ^a   Levine, Eric S ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

endocannabinoids; glutamatergic; neocortex; neuromodulators; neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMIC ACID;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EXCITATORY POSTSYNAPTIC POTENTIAL; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; SYNAPTIC TRANSMISSION; VISUAL CORTEX; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; MINIATURE ENDPLATE POTENTIAL; NEOCORTEX; PHYSIOLOGY; SYNAPSE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; ENDOCANNABINOIDS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; MICE; MICE, INBRED C57BL; MINIATURE POSTSYNAPTIC POTENTIALS; NEOCORTEX; PYRAMIDAL CELLS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, TRKB; SOMATOSENSORY CORTEX; SYNAPSES;

EID: 85012915595     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21962     Document Type: Article

References (71)

1. Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., … Galve-Roperh, I. (2007). The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. The Journal of Biological Chemistry, 282(33), 23892–23898.
2. Alder, J., Thakker-Varia, S., Crozier, R. A., Shaheen, A., Plummer, M. R., & Black, I. B. (2005). Early presynaptic and late postsynaptic components contribute independently to brain-derived neurotrophic factor-induced synaptic plasticity. The Journal of Neuroscience, 25(12), 3080–3085.
3. Alger, B. E. (2012). Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. The Journal of Physiology, 590(Pt 10), 2203–2212.
4. Aso, E., Ozaita, A., Valdizan, E. M., Ledent, C., Pazos, A., Maldonado, R., & Valverde, O. (2008). BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. Journal of Neurochemistry, 105(2), 565–572.
5. Atasoy, D., Ertunc, M., Moulder, K. L., Blackwell, J., Chung, C., Su, J., & Kavalali, E. T. (2008). Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap. The Journal of Neuroscience, 28(40), 10151–10166.
6. Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277(5329), 1094–1097.
7. Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., … Harkany, T. (2005). Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proceedings of the National Academy of Sciences of the United States of America, 102(52), 19115–19120.
8. Berninger, B., & Poo, M. (1996). Fast actions of neurotrophic factors. Current Opinion in Neurobiology, 6(3), 324–330.
9. Bodor, A. L., Katona, I., Nyiri, G., Mackie, K., Ledent, C., Hajos, N., & Freund, T. F. (2005). Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types. The Journal of Neuroscience, 25(29), 6845–6856.
10. Cabelli, R. J., Allendoerfer, K. L., Radeke, M. J., Welcher, A. A., Feinstein, S. C., & Shatz, C. J. (1996). Changing patterns of expression and subcellular localization of TrkB in the developing visual system. The Journal of Neuroscience, 16(24), 7965–7980.
11. Carmignoto, G., Pizzorusso, T., Tia, S., & Vicini, S. (1997). Brain-derived neurotrophic factor and nerve growth factor potentiate excitatory synaptic transmission in the rat visual cortex. The Journal of Physiology, 498 (Pt 1), 153–164.
12. Castillo, P. E., Younts, T. J., Chavez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron, 76(1), 70–81.
13. Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006). Endocannabinoid-mediated synaptic plasticity in the CNS. Annual Review of Neuroscience, 29, 37–76.
14. Crozier, R. A., Black, I. B., & Plummer, M. R. (1999). Blockade of NR2B-containing NMDA receptors prevents BDNF enhancement of glutamatergic transmission in hippocampal neurons. Learning Memory, 6(3), 257–266.
15. De Chiara, V., Angelucci, F., Rossi, S., Musella, A., Cavasinni, F., Cantarella, C., … Centonze, D. (2010). Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. The Journal of Neuroscience, 30(24), 8127–8137.
16. De Chiara, V., Motta, C., Rossi, S., Studer, V., Barbieri, F., Lauro, D., … Centonze, D. (2013). Interleukin-1beta alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience, 250, 232–239.
17. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., & Piomelli, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372(6507), 686–691.
18. Egertova, M., Cravatt, B. F., & Elphick, M. R. (2003). Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience, 119(2), 481–496.
19. Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the United States of America, 101(23), 8756–8761.
20. Fortin, D. A., & Levine, E. S. (2007). Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cerebral Cortex, 17(1), 163–174.
21. Freund, T. F., Katona, I., & Piomelli, D. (2003). Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews, 83(3), 1017–1066.
22. Fryer, R. H., Kaplan, D. R., Feinstein, S. C., Radeke, M. J., Grayson, D. R., & Kromer, L. F. (1996). Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. The Journal of Comparative Neurology, 374(1), 21–40.
23. Galve-Roperh, I., Chiurchiu, V., Diaz-Alonso, J., Bari, M., Guzman, M., & Maccarrone, M. (2013). Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Progress in Lipid Research, 52(4), 633–650.
24. Gibon, J., Barker, P. A., & Seguela, P. (2016). Opposing presynaptic roles of BDNF and ProBDNF in the regulation of persistent activity in the entorhinal cortex. Molecular Brain, 9, 23.
25. Hashimotodani, Y., Ohno-Shosaku, T., & Kano, M. (2007). Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. The Journal of Neuroscience, 27(5), 1211–1219.
26. Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry, 69(2), 631–638.
27. Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2012). Contributions of endocannabinoid signaling to psychiatric disorders in humans: Genetic and biochemical evidence. Neuroscience, 204, 207–229.
28. Huang, Y., Yasuda, H., Sarihi, A., & Tsumoto, T. (2008). Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice. The Journal of Neuroscience, 28(28), 7074–7083.
29. Huntwork, S., & Littleton, J. T. (2007). A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth. Nature Neuroscience, 10(10), 1235–1237.
30. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiological Reviews, 89(1), 309–380.
31. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. The Journal of Neuroscience, 19(11), 4544–4558.
32. Katona, I., Urban, G. M., Wallace, M., Ledent, C., Jung, K. M., Piomelli, D., … Freund, T. F. (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. The Journal of Neuroscience, 26(21), 5628–5637.
33. Katz, L. C., & Shatz, C. J. (1996). Synaptic activity and the construction of cortical circuits. Science, 274(5290), 1133–1138.
34. Khaspekov, L. G., Brenz Verca, M. S., Frumkina, L. E., Hermann, H., Marsicano, G., & Lutz, B. (2004). Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. The European Journal of Neuroscience, 19(7), 1691–1698.
35. Kreitzer, A. C., & Regehr, W. G. (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29(3), 717–727.
36. Leal, G., Afonso, P. M., Salazar, I. L., & Duarte, C. B. (2015). Regulation of hippocampal synaptic plasticity by BDNF. Brain Research, 1621, 82–101.
37. Lemtiri-Chlieh, F., & Levine, E. S. (2010). BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. Journal of Neurophysiology, 104(4), 1923–1932.
38. Lessmann, V., & Heumann, R. (1998). Modulation of unitary glutamatergic synapses by neurotrophin-4/5 or brain-derived neurotrophic factor in hippocampal microcultures: Presynaptic enhancement depends on pre-established paired-pulse facilitation. Neuroscience, 86(2), 399–413.
39. Levine, E. S., Crozier, R. A., Black, I. B., & Plummer, M. R. (1998). Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proceedings of the National Academy of Sciences of the United States of America, 95(17), 10235–10239.
40. Li, Y. X., Zhang, Y., Lester, H. A., Schuman, E. M., & Davidson, N. (1998). Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. The Journal of Neuroscience, 18(24), 10231–10240.
41. Lin, S. Y., Wu, K., Levine, E. S., Mount, H. T., Suen, P. C., & Black, I. B. (1998). BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Research Molecular Brain Research, 55(1), 20–27.
42. Littleton, J. T., Stern, M., Schulze, K., Perin, M., & Bellen, H. J. (1993). Mutational analysis of Drosophila synaptotagmin demonstrates its essential role in Ca(2+)-activated neurotransmitter release. Cell, 74(6), 1125–1134.
43. Lozovaya, N., Min, R., Tsintsadze, V., & Burnashev, N. (2009). Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects. Cell Calcium, 46(3), 154–162.
44. Luongo, L., Maione, S., & Di Marzo, V. (2014). Endocannabinoids and neuropathic pain: Focus on neuron-glia and endocannabinoid-neurotrophin interactions. The European Journal of Neuroscience, 39(3), 401–408.
45. Madara, J. C., & Levine, E. S. (2008). Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. Journal of Neurophysiology, 100(6), 3175–3184.
46. Maison, P., Walker, D. J., Walsh, F. S., Williams, G., & Doherty, P. (2009). BDNF regulates neuronal sensitivity to endocannabinoids. Neuroscience Letters, 467(2), 90–94.
47. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., … Lutz, B. (2003). CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science, 302(5642), 84–88.
48. Marsicano, G., & Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. The European Journal of Neuroscience, 11(12), 4213–4225.
49. Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993). Localization of cannabinoid receptor mRNA in rat brain. The Journal of Comparative Neurology, 327(4), 535–550.
50. Maximov, A., Shin, O. H., Liu, X., & Sudhof, T. C. (2007). Synaptotagmin-12, a synaptic vesicle phosphoprotein that modulates spontaneous neurotransmitter release. The Journal of Cell Biology, 176(1), 113–124.
51. Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47.
52. Melom, J. E., Akbergenova, Y., Gavornik, J. P., & Littleton, J. T. (2013). Spontaneous and evoked release are independently regulated at individual active zones. The Journal of Neuroscience, 33(44), 17253–17263.
53. Miller, M. W., & Pitts, F. A. (2000). Neurotrophin receptors in the somatosensory cortex of the mature rat: Co-localization of p75, trk, isoforms and c-neu. Brain Research, 852(2), 355–366.
54. Minichiello, L. (2009). TrkB signalling pathways in LTP and learning. Nature Reviews Neuroscience, 10(12), 850–860.
55. Pang, Z. P., Bacaj, T., Yang, X., Zhou, P., Xu, W., & Sudhof, T. C. (2011). Doc2 supports spontaneous synaptic transmission by a Ca(2+)-independent mechanism. Neuron, 70(2), 244–251.
56. Park, H., & Poo, M. M. (2013). Neurotrophin regulation of neural circuit development and function. Nature Reviews Neuroscience, 14(1), 7–23.
57. Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215.
58. Roloff, A. M., Anderson, G. R., Martemyanov, K. A., & Thayer, S. A. (2010). Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity. The Journal of Neuroscience, 30(8), 3072–3081.
59. Ronesi, J., Gerdeman, G. L., & Lovinger, D. M. (2004). Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. The Journal of Neuroscience, 24(7), 1673–1679.
60. Schinder, A. F., Berninger, B., & Poo, M. (2000). Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation. Neuron, 25(1), 151–163.
61. Szabo, G. G., Lenkey, N., Holderith, N., Andrasi, T., Nusser, Z., & Hajos, N. (2014). Presynaptic calcium channel inhibition underlies CB(1) cannabinoid receptor-mediated suppression of GABA release. The Journal of Neuroscience, 34(23), 7958–7963.
62. Trettel, J., Fortin, D. A., & Levine, E. S. (2004). Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. The Journal of Physiology, 556(Pt 1), 95–107.
63. Trettel, J., & Levine, E. S. (2002). Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. Journal of Neurophysiology, 88(1), 534–539.
64. Tsou, K., Brown, S., Sanudo-Pena, M. C., Mackie, K., & Walker, J. M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83(2), 393–411.
65. Tyler, W. J., & Pozzo-Miller, L. D. (2001). BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. The Journal of Neuroscience, 21(12), 4249–4258.
66. Vinod, K. Y., Xie, S., Psychoyos, D., Hungund, B. L., Cooper, T. B., & Tejani-Butt, S. M. (2012). Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats. PLoS One, 7(5), e36743.
67. Yeh, M. L., Gonda, Y., Mommersteeg, M. T., Barber, M., Ypsilanti, A. R., Hanashima, C., … Andrews, W. D. (2014). Robo1 modulates proliferation and neurogenesis in the developing neocortex. The Journal of Neuroscience, 34(16), 5717–5731.
68. Yoshihara, M., Ueda, A., Zhang, D., Deitcher, D. L., Schwarz, T. L., & Kidokoro, Y. (1999). Selective effects of neuronal-synaptobrevin mutations on transmitter release evoked by sustained versus transient Ca2+ increases and by cAMP. The Journal of Neuroscience, 19(7), 2432–2441.
69. Zhao, L., & Levine, E. S. (2014). BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling. Journal of Neurophysiology, 111(5), 1008–1015.
70. Zhao, L., Yeh, M. L., & Levine, E. S. (2015). Role for endogenous BDNF in endocannabinoid-mediated long-term depression at neocortical inhibitory synapses. eNeuro, 2(2).
71. Zhong, P., Liu, Y., Hu, Y., Wang, T., Zhao, Y. P., & Liu, Q. S. (2015). BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. The Journal of Neuroscience, 35(10), 4469–4481.